METPRO: Evaluating prognostic value of c-Met protein overexpression and concurrent biomarker presence

被引：0
|
作者：
Le, X. [1 ]
Aggarwal, C. [2 ]
Simmons, A. [3 ]
Crawford, S. A. [3 ]
Ng, S. [3 ]
Chen, C. [3 ]
Karve, S. [3 ]
Stein, S. [3 ]
Woll, K. [3 ]
Ansell, P. J. [3 ]
Mistry, A. [3 ]
Bryant, D. [4 ]
Wistuba, I. I. [1 ]
机构：
[1] MD Anderson, Thorac Head & Neck, Houston, TX USA
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Penn Ctr Canc Care Innovat, Philadelphia, PA USA
[3] AbbVie Inc, US Med Affairs, N Chicago, IL USA
[4] Caris Life Sci, Oncol, Dallas, TX USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1360
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1303P
引用
收藏
页码：S829 / S829
页数：1
相关论文
共 50 条
  • [31] Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer
    Boromand, Nadia
    Hasanzadeh, Malihe
    ShahidSales, Soodabeh
    Farazestanian, Marjaneh
    Gharib, Masoumeh
    Fiuji, Hamid
    Behboodi, Negin
    Ghobadi, Niloofar
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (06) : 4490 - 4496
  • [32] Prognostic Significance of c-Met Expression in Glioblastomas
    Kong, Doo-Sik
    Song, Sang-Yong
    Kim, Duk-Hwan
    Joo, Kyeung Min
    Yoo, Jin-San
    Koh, Jong Sung
    Dong, Seung Myung
    Suh, Yeon-Lim
    Lee, Jung-Il
    Park, Kwan
    Kim, Jong Hyun
    Nam, Do-Hyun
    CANCER, 2009, 115 (01) : 140 - 148
  • [33] Differential overexpression of c-Met oncogene in melanoma metastasis
    Wilson, LL
    Takeuchi, H
    Kuo, C
    Hoon, DS
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S43 - S44
  • [34] c-MET as a prognostic biomarker and therapeutic target in patients with poor prognostic pancreatic adenocarcinoma following surgical resection
    Neuzillet, Cindy
    Cros, Jerome
    Tijeras-Raballand, Annemilai
    Moroch, Julien
    De Mestier, Louis
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    De Gramont, Armand
    Cvitkovic, Esteban
    Raymond, Eric
    Hammel, Pascal
    Couvelard, Anne
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Overexpression of gastrin and c-met protein involved in human gastric carcinomas and intestinal metaplasia
    Tang, ZB
    Zhao, M
    Jiafu, JF
    Yang, GB
    Hu, FL
    He, JS
    Shen, H
    Gao, Z
    Zhao, A
    Li, JY
    Lu, YY
    ONCOLOGY REPORTS, 2004, 11 (02) : 333 - 339
  • [36] Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma
    van Boxtel, Wim
    Uijen, Maike J. M.
    Verhaegh, Gerald W.
    Willems, Stefan M.
    Jonker, Marianne A.
    Schalken, Jack A.
    Van Engen-van Grunsven, Ilse C. H.
    van Herpen, Carla M. L.
    ORAL ONCOLOGY, 2020, 110
  • [37] C-MET PROTEIN AS A COLORECTAL CANCER BIOMARKER FOR FLUORESCENCE IMAGE-GUIDED SURGERY
    Armstrong, G.
    Portal, C.
    Khot, M. I.
    West, N. P.
    Maisey, T.
    Perry, S.
    Tolan, D.
    Jayne, D. G.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [38] Autocrine c-met/HGF HCC patient derived xenograft (PDX) models for evaluating c-met inhibitors
    Chen, Dawei
    Song, Xiaoming
    Call, Jie
    Chen, Taiping
    Chen, Yiyou
    Li, Henry Q. X.
    CANCER RESEARCH, 2012, 72
  • [39] c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
    Sawada, Kenjiro
    Radjabi, A. Reza
    Shinomiya, Nariyoshi
    Kistner, Emily
    Kenny, Hilary
    Becker, Amy R.
    Turkyilmaz, Muge A.
    Salgia, Ravi
    Yamada, S. Diane
    Vande Woude, George F.
    Tretiakova, Maria S.
    Lengyel, Ernst
    CANCER RESEARCH, 2007, 67 (04) : 1670 - 1679
  • [40] Prognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma
    Li, Yingqin
    Li, Wenfei
    He, Qingmei
    Xu, Yafei
    Ren, Xianyue
    Tang, Xinran
    Wen, Xin
    Yang, Xiaojing
    Sun, Ying
    Zeng, Jing
    Yun, Jingping
    Liu, Na
    Ma, Jun
    ONCOTARGET, 2015, 6 (15) : 13309 - 13319
12345